A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats
Ajeesh Koshy Cherian, Howard Gritton, David E. Johnson, Damon Young, Rouba Kozak, Martin Sarter
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats'. Together they form a unique fingerprint.